Ayman Sahli joined Gulf Pharmaceuticals Industries – or Julphar as it is more widely known - in 2008 as general manager.
But, having excelled in leading the company and strengthening its operations through networking with various countries and their respective pharmaceuticals markets, Sahli was appointed as CEO. He is a holder of a doctorate in chemistry and specialises in pharmaceutical research and manufacturing.
Earlier this year, Julphar opened its first overseas plant, in Ethiopia. More are on the way, with factories planned for both Saudi Arabia and Algeria.